These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22373580)

  • 1. Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer.
    Kim JJ; Kim JT; Yoon HR; Kang MA; Kim JH; Lee YH; Kim JW; Lee SJ; Song EY; Myung PK; Lee HG
    Tumour Biol; 2012 Jun; 33(3):731-8. PubMed ID: 22373580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer.
    Kim TW; Lee SJ; Kim JT; Kim SJ; Min JK; Bae KH; Jung H; Kim BY; Lim JS; Yang Y; Yoon DY; Choe YK; Lee HG
    Oncotarget; 2016 Dec; 7(51):85332-85348. PubMed ID: 27863404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer.
    Nagahara H; Mimori K; Utsunomiya T; Barnard GF; Ohira M; Hirakawa K; Mori M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6800-6. PubMed ID: 16203767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells.
    Henkhaus RS; Gerner EW; Ignatenko NA
    Biol Chem; 2008 Jun; 389(6):757-64. PubMed ID: 18627290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer.
    Kim JT; Song EY; Chung KS; Kang MA; Kim JW; Kim SJ; Yeom YI; Kim JH; Kim KH; Lee HG
    Cancer; 2011 Jun; 117(12):2608-19. PubMed ID: 21656738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.
    Sells E; Pandey R; Chen H; Skovan BA; Cui H; Ignatenko NA
    Neoplasia; 2017 May; 19(5):396-411. PubMed ID: 28431272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.
    Sidiropoulos KG; Ding Q; Pampalakis G; White NM; Boulos P; Sotiropoulou G; Yousef GM
    Mol Oncol; 2016 Aug; 10(7):993-1007. PubMed ID: 27093921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells.
    Henkhaus RS; Roy UK; Cavallo-Medved D; Sloane BF; Gerner EW; Ignatenko NA
    Neoplasia; 2008 Feb; 10(2):140-8. PubMed ID: 18283336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallikrein-related peptidase 6 (KLK6) expression in the progression of colon adenoma to carcinoma.
    Vakrakou A; Devetzi M; Papachristopoulou G; Malachias A; Scorilas A; Xynopoulos D; Talieri M
    Biol Chem; 2014 Sep; 395(9):1105-17. PubMed ID: 25153391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.
    Ogawa K; Utsunomiya T; Mimori K; Tanaka F; Inoue H; Nagahara H; Murayama S; Mori M
    Clin Cancer Res; 2005 Apr; 11(8):2889-93. PubMed ID: 15837738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).
    Bayani J; Diamandis EP
    Clin Chem Lab Med; 2011 Nov; 50(2):211-33. PubMed ID: 22047144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancer.
    Liu X; Xiong H; Li J; He Y; Yuan X
    Diagn Pathol; 2013 Apr; 8():62. PubMed ID: 23587030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
    Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kallikrein-related peptidase 6 (KLK6)gene expression in intracranial tumors.
    Talieri M; Zoma M; Devetzi M; Scorilas A; Ardavanis A
    Tumour Biol; 2012 Oct; 33(5):1375-83. PubMed ID: 22477710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients.
    Haritos C; Michaelidou K; Mavridis K; Missitzis I; Ardavanis A; Griniatsos J; Scorilas A
    Clin Exp Med; 2018 May; 18(2):203-213. PubMed ID: 29435805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
    Grin A; Samaan S; Tripathi M; Rotondo F; Kovacs K; Bassily MN; Yousef GM
    Hum Pathol; 2015 Apr; 46(4):541-8. PubMed ID: 25649006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
    Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
    Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
    Kaneko N; Kawano S; Yasuda K; Hashiguchi Y; Sakamoto T; Matsubara R; Goto Y; Jinno T; Maruse Y; Morioka M; Hattori T; Tanaka S; Tanaka H; Kiyoshima T; Nakamura S
    Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis.
    Bouzid H; Soualmia F; Oikonomopoulou K; Soosaipillai A; Walker F; Louati K; Lo Dico R; Pocard M; El Amri C; Ignatenko NA; Darmoul D
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion.
    Klucky B; Mueller R; Vogt I; Teurich S; Hartenstein B; Breuhahn K; Flechtenmacher C; Angel P; Hess J
    Cancer Res; 2007 Sep; 67(17):8198-206. PubMed ID: 17804733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.